National Plan for Universal Mental Health Screening:A Pharma Friendly Remedy for Societal Problems

Download the complete powerpoint presentation

Text of power point presentation:

Slide 2: I’ll begin with the President’s New Freedom Commission on Mental Health[1] recommendation to screen the US population for mental illness – 52 million children first. In no other democratic country has the government adopted a policy to screen the population for presumed, undetected, mental illness. The rationale behind this mind-boggling Orwellian nightmare is not improving mental health, but rather increasing life-long consumers of psychoactive drugs and to control behavior. Two NFC recommendations are designed to do just that. TeenScreen is promoted as a suicide prevention model when it in fact, increases the number of children labeled suicidal and depressed.

UK Parliament Report Re: Pharma Influence / US Regulators Comatose as 258 Fatal Suicides Linked to Neurontin

UK Parliament Report Re: Pharma Influence / US RegulatorsComatose as 258 Fatal Suicides Linked to Neurontin Wed, 6 Apr 2005 The Health Committee of the British House of Commons, has just released its report, “The Influence of the Pharmaceutical Industry.” This landmark document is not just of value to UK…

Testimony of Meryl Nass, MD – Senate HELP Committee, Subcommittee on Bioterrorism

Thank you for the opportunity to submit this testimony for the record.

My name is Meryl Nass, M.D., and I have worked for the past twenty years as an emergency physician and internist in community hospitals in the northeastern US. I have also studied many aspects of bioterrorism since 1989. I am the person who first demonstrated, in 1992, that one could investigate an epidemic retrospectively, and prove that it was due to biological warfare, using Rhodesia’s 1978-80 anthrax epidemic as a model.[1]

AHRP Press Statement – FDA & SSRI Suicide Risk 9/14/04

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org ***PRESS STATEMENT*** Re: The FDA & Concealment of Suicide-Related Risks of Antidepressants Date: September 14, 2004 Contact: Vera Hassner Sharav, President   We are witnessing the unraveling of a system that was intended to ensure that marketed drugs met high safety standards; that…

Press Statement – FDA & Concealment of Suicide-Related Risks of Antidepressants

We are witnessing the unraveling of a system that was intended to ensure that marketed drugs met high safety standards; that physicians were informed about potential, serious adverse drug effects – so that they would prescribe judiciously; and that the integrity of the scientific literature was preserved. But that system has been hijacked by the drug industry – which has infected medical practice and medical research with detail men and informercials that make false claims while manipulating partial data to conceal adverse drug effects.

FDA’s Waiting Game Exposes Children to Preventable Risks – 9/04 AHRP Comments to FDA

FDA’s Waiting Game Exposes Children to Preventable Risks Comments by Vera Hassner Sharav President The Alliance for Human Research Protection Submitted to FDA Advisory Committee Psychopharmacological Drugs Advisory Committee and Pediatric Subcommittee Drugs Advisory Committee September 13-14, 2004 Meeting RE: Suicidality Associated with Antidepressant Drug Treatment The Alliance for Human…

Pfizer Lawsuits: Zoloft / Neurontin Concealed Evidence: Suicide Risk/ Lack of Efficacy

Pfizer Lawsuits: Zoloft / Neurontin Concealed Evidence: Suicide Risk/ Lack of Efficacy Mon, 26 Jul 2004 On July 23, 2004, a citizen’s consumer protection lawsuit was filed against Pfizer Pharmaceuticals for concealment of evidence and deceptive marketing of the antidepressant Zoloft. The California law firm of Baum Hedlund has filed…

FDA Failed to Enforce Law Requiring Drugmakers to Disclose Test Data – WashPost

FDA Failed to Enforce Law Requiring Drugmakers to Disclose Test Data – WashPost Tue, 6 Jul 2004 A front page article in The Washington Post reports that the FDA failed to enforce the law that requires drug companies to disclose ALL clinical drug trials and ALL trial findings-whether they’re good…

Forest Labs Admits Concealment of data – Congressional Probe Expands

Forest Labs Admits Concealment of data – Congressional Probe Expands Sat, 26 Jun 2004 New York Times business reporter, Barry Meier, reports, “Forest officials had not told a medical journal about a failed unpublished study in 2002 of Celexa use in children and adolescents, before the journal published an article…